Biortica Agrimed will ship 18 new genetics to Australia next week, pushing the total number of new varieties the company has introduced to the country to 49.
CEO Tom Varga said the company's stake in Canadian genetics business Apollo Green was starting to yield results.
"We've always believed that to produce the very best medicinal cannabis you have to grow the very best plants… [and the way to do that] is to first invest in the best genetics."
He added: "Our investment in Apollo Green… is now really beginning to deliver. International enquiries are increasing significantly, however the Australian industry, and Australian patients, will always be a key focus for Biortica."
SOMAÍ Pharmaceuticals
SOMAÍ Pharmaceuticals has introduced a range of mint-flavoured oral solutions to the Australian market after identifying flavour as a key element in ensuring patients maintain treatment.
The indica oils are now accessible in various ratios through the special access and authorised prescriber schemes.
SOMAÍ is expanding its product offerings in Australia as it follows through on its commitment to give doctors and patients a reliable and diverse supply of medicinal cannabis.
